Annexon (ANNX) Competitors

Nurix Therapeutics (NASDAQ:NRIX) and Annexon (NASDAQ:ANNX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.

Does the MarketBeat Community favor NRIX or ANNX?

Nurix Therapeutics received 29 more outperform votes than Annexon when rated by MarketBeat users. Likewise, 78.90% of users gave Nurix Therapeutics an outperform vote while only 78.08% of users gave Annexon an outperform vote.

Company	Underperform	Outperform
Nurix Therapeutics	Outperform Votes 86 78.90%	Underperform Votes 23 21.10%
Annexon	Outperform Votes 57 78.08%	Underperform Votes 16 21.92%

Which has more volatility & risk, NRIX or ANNX?

Nurix Therapeutics has a beta of 2.23, indicating that its share price is 123% more volatile than the S&P 500. Comparatively, Annexon has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.

Is NRIX or ANNX more profitable?

Annexon has a net margin of 0.00% compared to Nurix Therapeutics' net margin of -354.85%. Annexon's return on equity of -38.99% beat Nurix Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nurix Therapeutics	-354.85%	-53.65%	-38.59%
Annexon	N/A	-38.99%	-33.90%

Does the media favor NRIX or ANNX?

In the previous week, Annexon had 3 more articles in the media than Nurix Therapeutics. MarketBeat recorded 17 mentions for Annexon and 14 mentions for Nurix Therapeutics. Nurix Therapeutics' average media sentiment score of 1.31 beat Annexon's score of 0.32 indicating that Nurix Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nurix Therapeutics	11 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Annexon	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher earnings & valuation, NRIX or ANNX?

Annexon has lower revenue, but higher earnings than Nurix Therapeutics. Nurix Therapeutics is trading at a lower price-to-earnings ratio than Annexon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nurix Therapeutics	$56.42M	13.07	-$193.57M	-$2.80	-3.45
Annexon	N/A	N/A	-$134.24M	-$1.18	-1.69

Do analysts rate NRIX or ANNX?

Nurix Therapeutics currently has a consensus price target of $30.44, suggesting a potential upside of 214.83%. Annexon has a consensus price target of $12.50, suggesting a potential upside of 526.57%. Given Annexon's stronger consensus rating and higher probable upside, analysts clearly believe Annexon is more favorable than Nurix Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nurix Therapeutics	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84
Annexon	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Annexon beats Nurix Therapeutics on 9 of the 15 factors compared between the two stocks.